Could 'open innovation' models that have proved successful in other sectors be fruitfully adopted by the pharmaceutical industry? In the past, the business model adopted by most high-tech ...

Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 ...